Product revenue guides up 14% sequentially while royalties guide down $9-15M at midpoint. EPS guide midpoint is up one cent.
Thesis: Q2 and Q3 are a genuine beat-and-raise with 20% product growth tied to Intel's 8-to-12 channel move and DDR5 sub-generation share capture. But every incremental revenue dollar is coming from 60-63% GM product while the near-pure-margin royalty stream guides down $9-15M sequentially. The stock works only if 2027 drivers (MRDIMM 4x content, companion chips to mid-double-digit mix, hyperscaler HBM license) arrive on time while Rambus sits on $16M of new inventory against its own admitted platform-slip risk.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q3 product revenue landing at or above the $110-116M guide, plus hyperscaler HBM and PCIe 7 license revenue booking in coming quarters ahead of end-product ramps.
Key Risk: Platform ramps slip beyond 2027 and the $16M inventory build sits while royalties keep declining. Luc himself concedes 'platform ramps typically take a little bit longer than what people anticipate.'
The Tell: Luc, unprompted after a question on DRAM pricing dynamics: 'because we have standard products, we don't see any opportunity, I would say, for price increases... We want to stay competitive and maintain or continue to increase our share in the DIMM markets.' In a supply chain he just called tight through 2027, he volunteers that the constraint earns them nothing.
Friction Level: MODERATE_FRICTION — Both sides agree on the facts: royalties falling to $69-75M from $84.2M, product up 22%, no price increases possible. Disagreement is whether mix shift toward 60-63% GM product is diversification or quality-of-revenue decay.
2026Q2 · Jul 27, 2026
4 of 5 readings agreed4 HOLD · 1 LONGRead the full call
Record Quarter, Royalty Line Guided Down $12M Sequentially
Q2 and Q3 are a genuine beat-and-raise with 20% product growth tied to Intel's 8-to-12 channel move and DDR5 sub-generation share capture. But every incremental revenue dollar is coming from 60-63% GM product while the near-pure-margin royalty stream guides down $9-15M sequentially. The stock works only if 2027 drivers (MRDIMM 4x content, companion chips to mid-double-digit mix, hyperscaler HBM license) arrive on time while Rambus sits on $16M of new inventory against its own admitted platform-slip risk.
Luc, unprompted after a question on DRAM pricing dynamics: 'because we have standard products, we don't see any opportunity, I would say, for price increases... We want to stay competitive and maintain or continue to increase our share in the DIMM markets.' In a supply chain he just called tight through 2027, he volunteers that the constraint earns them nothing.
Beat high end of guide with $207.4M revenue, record $99.2M product, non-GAAP EPS $0.77 +24% YoY, then guided Q3 revenue $210-216M and product $110-116M. Third straight quarter of double-digit YoY product growth.
Q3 royalties guide $69-75M vs $84.2M actual, down $9-15M sequentially, while product absorbs the gap at 60-63% GM vs the high-margin royalty stream. Management redirects the margin question to annual averages.
Luc: 'because we have standard products, we don't see any opportunity for price increases... we want to stay competitive and maintain or continue to increase our share.' Lead times lengthening, no monetization of the constraint.
Company inventory rose $16M while Luc states 'we don't see any signs of our customers building inventory.' Rambus holds the inventory risk on its own balance sheet ahead of ramps it admits could slip.
Tier-1 U.S. hyperscaler engaged on next-gen HBM IP before specifications finalized; CXMT licensing memory IP. Architectural lock-in at the design stage, license revenue booked ahead of product shipping.
-25
CAUTIOUS"'Confidence continues to build' repeated three times, yet Luc refuses to guide past one quarter and cites platform timing plus supply tightness through 2027 as the two hedges. Direct answers, forward caution."
Full transcript with specific segment guides, gross margin bands, inventory delta, and direct admissions on pricing. Only soft spot: no unit or content-per-server numbers disclosed.
Q3 product revenue landing at or above the $110-116M guide, plus hyperscaler HBM and PCIe 7 license revenue booking in coming quarters ahead of end-product ramps.
Platform ramps slip beyond 2027 and the $16M inventory build sits while royalties keep declining. Luc himself concedes 'platform ramps typically take a little bit longer than what people anticipate.'
“We expect revenue in the Q2 to be between $192 million and $198 million.”
“Revenue for the second quarter was $207.4 million, which is up 20% year-over-year and up 15% sequentially, led by strong performances from our product and royalties revenue.”
Companies tend to guide low: the median company we cover reports +1.7% against its guidance midpoint, so a small beat is the norm. A transcript can drop part of a guided range, so read both quotes.
“We expect revenue in the third quarter to be between $210 million and $216 million.”
Changed less than 75% of calls
Wording compared with the Apr 27, 2026 call, ranked among 98 calls reporting on Q2 2026. A measure of how much the story moved, not a signal about the stock.
Figures are extracted from the transcripts and checked in code: every quote appears word for word. Language change is computed from word frequencies, with no model involved. Descriptive only: none of this feeds the verdict.
Real beat-and-raise: $207.4M revenue +20% YoY, product record $99.2M +22%, EPS $0.77 +24%, $825M cash, $61M OCF. Q3 guide $210-216M with product $110-116M is a 14% sequential product jump. Growth is unit-driven: Intel moved 8 to 12 channels, market going to 16, Gartner server units at 12% and Rambus growing faster. New products go from low double-digit to mid double-digit percent of a growing base by Q4. MRDIMM carries 4x silicon content and ramps both CPU platforms in 2027. Hyperscaler HBM IP win landed before standards were final, and PCIe 7 licenses book revenue in coming quarters, well before end products ship. CXMT and every new Chinese memory maker become royalty streams at zero marginal cost. Street still prices this as a licensing relic.
Royalty stream, the near-pure-margin IP income, guides from $84.2M to $69-75M. Product fills the hole at 60-63% GM, below the 60-65% model, and management deflects to annual averages. Zero pricing power admitted outright despite lead times lengthening through 2027: standard products, must defend share. Company built $16M of inventory while confirming customers built none, so if ramps slip the risk sits on Rambus. Every growth driver past the current DDR5 RCD cycle is pushed right: MRDIMM minimal in Q4, material only 2027; PCIe 6.0, companion chips, SOCAMM2 all 2027 stories. Confidence language rose while the guidance horizon shrank to one quarter. EPS guide midpoint of $0.785 on 14% sequential product growth shows the mix is not flowing to the bottom line.
Zero Pricing Power Despite Constraints
CEO states no opportunity for price increases on standard products while confirming lead times lengthening and tightness through 2027. A supplier that cannot raise ASP in a constrained market captures none of the scarcity value.
Mix Shift Spin
Royalties guide down $9-15M sequentially into lower-margin product. Blended margin composition deteriorates while headline growth rises; CFO reinforces '60-63%' against a 60-65% model.
Inventory Divergence
$16M inventory build on Rambus's balance sheet against management's own admission that platform ramps 'typically take a little bit longer.' Customer channel clean; company holds the risk.
Unsustainable Trend Confidence
'Confidence continues to build' repeated while refusing to guide past Q4 and citing supply and platform timing as the two hedges. Confidence up, visibility down.
HOLD at medium conviction. Near-term is clean: beat-and-raise with Q3 product guide +14% sequential and cash at $825M. But the asymmetry is unattractive. Upside requires 2027 drivers (MRDIMM, companion chips, hyperscaler licenses) to land on time while downside is a royalty miss plus $16M of inventory sitting. Cannot size the risk when the growth case lives three quarters out and the current quarter's EPS guide midpoint is up one cent on 14% product growth. Wait for either a Q4 royalty stabilization or evidence MRDIMM volumes are tracking. No price exists in a tight market you don't control.